Senior Manager/Associate Director, SEC Reporting

Remix launched with a vision to transform patients’ lives through modulation of RNA processing. Our breakthrough science enables the identification of small molecules that influence the expression of disease ‑ driving mRNAs and proteins. We focus on diseases of high unmet medical need and are committed to operating with scientific rigor and urgency. With a proprietary in ‑ house technology platform, we have rapidly generated multiple discovery programs advancing toward the clinic. Remix Therapeutics was recognized as one of BioSpace’s Best Places to Work in Boston 2025 and is backed by leading life sciences investors.

Position Summary:

The Senior Manager/Associate Director, SEC Reporting will play a critical role in supporting public company readiness initiatives and leading external financial reporting activities. Reporting to the Head of Finance, this individual will be responsible for preparing SEC filings, supporting technical accounting matters, and helping establish scalable reporting and compliance processes appropriate for a public company environment. The ideal candidate will bring strong technical accounting expertise, excellent project management capabilities, and the ability to work independently in a fast-paced clinical-stage biotech environment.

This is an exciting opportunity to join a growing clinical-stage biotechnology company at a transformational stage and help build the infrastructure of a future public company. The role offers meaningful exposure to executive leadership, opportunities for professional growth, and the ability to make a significant impact on the organization’s future success.

Key Responsibilities:

Prepare and coordinate SEC filings, including Forms S-1, 10-Q, 10-K, 8-K, and related disclosures and supporting schedules

Draft and review footnote disclosures and MD&A in accordance with U.S. GAAP and SEC reporting requirements

Support IPO readiness activities, including implementation of disclosure controls and SOX compliance processes

Partner cross-functionally with FP&A, Legal, HR, Clinical Operations, and external auditors/advisors to gather and validate information for filings

Research technical accounting matters and prepare accounting memoranda

Coordinate reporting timelines and ensure timely and accurate filings

Support quarterly and annual close activities related to external reporting

Assist with equity accounting and stock compensation reporting

Monitor new accounting pronouncements and SEC regulations and assess their impact on the company

Drive process improvements and help build scalable reporting infrastructure as the organization grows

Personal Attributes:

Highly detail-oriented with strong analytical and problem-solving skills

Hands-on, proactive, and solutions-oriented mindset

Comfortable operating in a dynamic, fast-paced environment

Collaborative team player with strong interpersonal skills

Ability to maintain confidentiality and exercise sound judgment

Qualifications:

Required

Bachelor's degree in accounting or finance

Active CPA license required

Minimum 5+ years of progressive accounting and financial reporting experience

Big 4 public accounting experience

Clinical-stage biotechnology or life sciences industry experience

Strong understanding of U.S. GAAP and SEC reporting requirements

Strong written and verbal communication skills

Demonstrated ability to work independently and drive projects to completion with minimal supervision

Excellent project management and organizational skills with the ability to manage multiple priorities and deadlines

Preferred

Master’s degree

Experience supporting IPO readiness and/or operating in a pre-public or newly public company environment

Advanced Excel skills and familiarity with reporting systems

Salary Range

$157,000.00 - $230,000.00 USD

This range reflects the expected base salary for this position, plus bonus, equity, and benefits as applicable. Actual salaries may vary based on factors, such as skill, experience, and qualification for the role.